🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to assess the safety, reactogenicity, and immun...
Status
Completed
Location
Optimal Research
Start Date
2020-07-15
Trial ID
NCT04436276
Treatments Being Tested
Few patients receiving SARS-CoV-2 vaccines may experience rare but serious ...
Status
Completed
Location
Alexandre Joachim
Start Date
2021-12-10
Trial ID
NCT05178264
Treatments Being Tested
The goal of this study is to determine what effect Cetaphil® Restoraderm® s...
Status
Completed
Location
Oregon Health & Science University Center for Health & Healing
Start Date
2011-06
Trial ID
NCT01375205
Treatments Being Tested
The purposes of this study are to demonstrate the non-inferiority (NI) of t...
Status
Completed
Location
Central Phoenix Medical Clinic
Start Date
2021-08-06
Trial ID
NCT04999111
Treatments Being Tested
The purpose of this study is to demonstrate non-inferiority (NI) in terms o...
Status
Completed
Location
Baptist Health Center For Clinical Research
Start Date
2021-06-18
Trial ID
NCT04908722
Treatments Being Tested
This study is a non-randomized observation and comparison of immune respons...
Status
Recruiting
Location
Shoklo Malaria Research Unit (SMRU)
Start Date
2023-04-15
Trial ID
NCT05571735
Treatments Being Tested
Assessment of SARS-CoV2 (mRNA and adenovirus-based vaccines) and Conjugated...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2020-07-16
Trial ID
NCT05007860
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel cor...
Status
Completed
Location
Victoria Biomedical Research Institute
Start Date
2022-05-18
Trial ID
NCT07408297
The purpose of this study: to assess the safety, tolerability and immunogen...
Status
Unknown
Location
Federal state budgetary institution "Central clinical hospital with polyclinic" Of the office Of the President of the Russian Federation
Start Date
2020-10-22
Trial ID
NCT04587219
Treatments Being Tested
The study will evaluate the efficacy of Ad26.COV2.S in the prevention of mo...
Status
Completed
Location
Synexus Clinical Research US Inc
Start Date
2020-09-07
Trial ID
NCT04505722
Treatments Being Tested